Fibroblasts as immune regulators in infection, inflammation and cancerSarah Davidson, Christopher D. Buckley, Mark Coles et al.|Nature reviews. Immunology|2021Cited by 597
IL-1-driven stromal–neutrophil interactions define a subset of patients with inflammatory bowel disease that does not respond to therapiesMatthias Friedrich, Mathilde Pohin, Matthew Jackson et al.|Nature Medicine|2021Cited by 289
Female survivors of intimate partner violence and risk of depression, anxiety and serious mental illnessJoht Singh Chandan, Julie Taylor, Tom Thomas et al.|The British Journal of Psychiatry|2019Cited by 202
Review article: managing the adverse events caused by anti‐TNF therapy in inflammatory bowel diseaseUday N. Shivaji, Neeraj Bhala, C Sharratt et al.|Alimentary Pharmacology & Therapeutics|2019Cited by 155